Effects of Mucosamin Spray on Preventing Oral Mucositis due to Chemotherapy

Investigating the Effectiveness of Mucosamin Spray as a Complementary Medicine in Prevention of Oral Mucositis in Children Under Chemotherapy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190705044106N1

Enrollment

Registered

2019-07-22

Start date

2019-05-28

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia, Lymphoma, oral mucositis. Hodgkin lymphoma

Interventions

Intervention 1: Intervention group: in addition to the three compound mouthwash (nystatin, aluminum MgS and diphenhydramine), mucosamin spray was sprayed three times a day on all the patient's oral mu

Eligibility

Sex/Gender

All

Age

5 Years to 15 Years

Inclusion criteria

Inclusion criteria: Children between the age of 5 and 15 Diagnosed with leukemia and lymphoma Under chemotherapy with specific drugs Under induction phase of chemotherapy Practicing acceptable oral hygiene

Exclusion criteria

Exclusion criteria: Usage of orthodontic appliance Diagnosed with autoimmune disease Having toothache or severe caries

Design outcomes

Primary

Measure	Time frame
Severity of oral mucositis. Timepoint: From the first day of chemotherapy to one month after. Method of measurement: According to the WHO classification for oral mucositis.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Tavasoli Hojati

Islamic Azad University

tavasolisara@yahoo.com+98 21 2256 4571

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026